Food News and Research

RSS

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Researchers at the University of Cincinnati begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells.

7 Aug 2017

‘Bureaucratic ninjas’ slice red-tape to battle health disparities

When a receptionist hands out a form to fill out at a doctor’s office, the questions are usually about medical issues: What’s the visit for? Are you allergic to anything? Up to date on vaccines?

7 Aug 2017

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Smell loss linked to worse nutritional status in patients with chronic kidney disease

A new study indicates that many patients with chronic kidney disease (CKD) have some degree of smell loss, and that impairments in patients' ability to smell are linked with worse nutritional status.

4 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

New study shows how gut microbes can prevent severe flu infections in mice

Microbes that live in the gut don't just digest food. They also have far-reaching effects on the immune system.

3 Aug 2017

Protein-rich diet may foster more tolerant, less inflammatory gut environment

Immune cells patrol the gut to ensure that harmful microbes hidden in the food we eat don't sneak into the body. Cells that are capable of triggering inflammation are balanced by cells that promote tolerance, protecting the body without damaging sensitive tissues.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Gene-therapy administered through skin transplants could enable treatment of many diseases

A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases.

3 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

Loyola participating in landmark study to examine use of PET scans to detect Alzheimer’s disease

Loyola Medicine is participating in a landmark $100 million study of the effectiveness of using PET scans to detect Alzheimer's disease.

3 Aug 2017

Biologic substance APOSEC shows promise for healing dermal wounds

APOSEC is a substance obtained from white blood corpuscles and was developed by a research group led by thoracic surgeon Hendrik Jan Ankersmit, Head of the Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration at MedUni Vienna.

3 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

Mango intake exerts beneficial effects in progression and severity of IBD

Initial results of a study by researchers in the department of nutrition and food science at Texas A&M University in College Station show mango consumption has a positive impact on people with inflammatory bowel disease.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Loss of dietary protein from food as carbon dioxide emissions fail to fall - warn researchers

According to researchers at the Harvard T.H. Chan School of Public Health, if the present rates of carbon dioxide emissions do not stop, people in around 18 countries worldwide may face a loss of around 5% of the protein they obtain from their diet by 2015. This is due to the reduction in the nutrient values of crops such as rice, wheat and other staples. This would put an additional 150 million people at risk of dietary protein deficiency. This is the first study that actually quantifies the actual dietary health risk posed by greenhouse gas emissions.

2 Aug 2017

Kitchen sponges - play house for millions of bacteria - fresh study reports

Scientists in Germany have looked into the minute pores of a common kitchen sponge and found dreaded bacteria that could make us very ill. This is the first comprehensive study to do so. The study was published this week in Scientific Reports. Researchers write that humans spend most of their time in built environments or BE and the microbial presence in these environments is termed BE microbiome. These microbes may have a great impact on human health and wellbeing.

2 Aug 2017

Food News and Research

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

‘Bureaucratic ninjas’ slice red-tape to battle health disparities

Tackling food allergies: is immunotherapy the answer?

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Smell loss linked to worse nutritional status in patients with chronic kidney disease

Experimental drug protects mice from obesity-related liver disease

New study shows how gut microbes can prevent severe flu infections in mice

Protein-rich diet may foster more tolerant, less inflammatory gut environment

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Gene-therapy administered through skin transplants could enable treatment of many diseases

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

Loyola participating in landmark study to examine use of PET scans to detect Alzheimer’s disease

Biologic substance APOSEC shows promise for healing dermal wounds

When wounds won’t heal, therapies spread — to the tune of $5 billion

Mango intake exerts beneficial effects in progression and severity of IBD

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Loss of dietary protein from food as carbon dioxide emissions fail to fall - warn researchers

Kitchen sponges - play house for millions of bacteria - fresh study reports

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News